Amgen

7 drugs likely to hit $1B in annual revenue in the next 5 years
Beckers Hospital Review
Thu, 01/13/22 - 07:31 am
FDA
adagrasib
donanemab
faricimab
lecanemab
tezepelumab
tirzepatide
vutrisiran
Eli Lilly
Mirati Therapeutics
Roche
Chugai
Eisai
Biogen
AstraZeneca
Amgen
Alnylam
JPM22, Day 3: In short order, Perrigo part of a new landscape; Legend, J&J prep for cilta-cel launch
Fierce Pharma
Wed, 01/12/22 - 11:22 pm
JPMHC 2022
Bausch Health
Amgen
Eli Lilly
Perrigo
JNJ
Legend Biotech
JPM22, Day 2: Freenome passes $1B funding mark; Amgen spices things up with Arrakis; Sage touts double-duty anxiety drug
Fierce Biotech
Tue, 01/11/22 - 11:43 am
JPMHC 2022
Freenome
Amgen
Roche
ThermoFisher Scientific
Amgen chooses Generate in $1.9B biobucks deal to churn out up to 10 multispecific drugs
Fierce Biotech
Thu, 01/6/22 - 12:36 pm
Amgen
Generate Biomedicines
biobucks
drug development
drug discovery
artificial intelligence
AstraZeneca, Amgen tap Brand Institute in new naming twist for their freshly approved Tezspire
Fierce Pharma
Thu, 01/6/22 - 11:52 am
Amgen
AstraZeneca
Broad Institute
asthma
Tezspire
drug names
Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers
Fierce Pharma
Fri, 12/31/21 - 11:10 am
patents
patent cliffs
Bristol Myers Squibb
Amgen
Pfizer
Revlimid
Eliquis
Enbrel
Otezla
Ibrance
Amgen builds Otezla’s psoriasis label as rival BMS looms large
Pharmaforum
Wed, 12/22/21 - 11:19 am
Amgen
Otezla
psoriasis
Bristol Myers Squibb
deucravacitinib
Abandoned by Amgen, Cy­to­ki­net­ics lands $50M upfront deal for Chinese rights to heart failure prospect
Fierce Biotech
Tue, 12/21/21 - 10:34 am
Cytokinetics
heart failure
Omecamtiv Mecarbil
Amgen
China
Ji Xing Pharmaceuticals
AstraZeneca and Amgen’s asthma biologic approved in the US
Biopharma Reporter
Mon, 12/20/21 - 11:08 am
AstraZeneca
Amgen
Tezspire
FDA
severe asthma
Bowing to pressure, J.P. Morgan says its health care conference will be virtual
Stat
Wed, 12/15/21 - 10:53 am
JPMHC 2022
virtual meetings
COVID-19
pandemic
Amgen
Moderna Therapeutics
Moderna, Amgen among biotech heavyweights pulling out of JPM conference over Covid concerns
Stat
Tue, 12/14/21 - 11:37 pm
JPMHC 2022
Amgen
Moderna
Sarepta Therapeutics
COVID-19
pandemic
Omicron COVID-19 variant
Amgen halts some drug discounts for safety net hospitals as SCOTUS takes on 340B case
Endpoints
Thu, 12/2/21 - 11:04 pm
Amgen
drug discounts
340B
Amgen's Otezla notches win in genital psoriasis, snagging possible edge against forthcoming BMS rival
Fierce Pharma
Thu, 12/2/21 - 12:25 pm
Amgen
Otezla
psoriasis
Bristol Myers Squibb
Amgen stalls Samsung's Enbrel biosim until 2029 in 2nd patent win of the year
Fierce Pharma
Wed, 12/1/21 - 10:14 am
Amgen
Enbrel
Samsung
biosimilars
patents
Amgen asks Supreme Court to take up its high-profile PCSK9 patent case against Sanofi and Regeneron
Fierce Pharma
Mon, 11/29/21 - 10:44 pm
Amgen
Sanofi
Regeneron
patents
Supreme Court
Repatha
Amgen's Otezla, Repatha and biosimilars put on notice, with challenging years ahead
Fierce Pharma
Mon, 11/22/21 - 10:13 pm
Amgen
biosimilars
Otezla
Repatha
Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds. Is it working?
Fierce Pharma
Mon, 11/22/21 - 10:21 am
migraines
pharma marketing
JNJ
Topamax
Amgen
Biohaven
Eli Lilly
Teva Pharmaceutical
Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers
BioSpace
Mon, 11/15/21 - 11:55 pm
Merck
PCSK9 inhibitors
Amgen
Repatha
Esperion
Sanofi
Regeneron
Praluent
Seeking an edge over Amgen, Mirati advances lower KRAS dose in Keytruda combo to improve tolerability
Fierce Biotech
Tue, 11/9/21 - 10:49 am
Mirati Therapeutics
Amgen
KRAS
clinical trials
Merck
Keytruda
Amgen breaks ground on New Albany, OH manufacturing plant of the future — report
Endpoints
Fri, 11/5/21 - 09:53 am
Amgen
drug manufacturing
Ohio

Pages